Newer anticoagulants for the prevention of venous thromboembolism.
Department of Clinical Haematology, Sir Ganga Ram Hospital, New Rajinder Nagar, New Delhi 110060, India. anupama.jaggia@sgrh.com
Anupama
A
Jaggia
D000925:Anticoagulants / Q000627:therapeutic use*; D000991:Antithrombins / Q000627:therapeutic use; D001120:Arginine / Q000031:analogs & derivatives; D001562:Benzimidazoles / Q000627:therapeutic use*; D000069604:Dabigatran; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use; D010875:Pipecolic Acids / Q000627:therapeutic use; D011720:Pyrazoles / Q000627:therapeutic use; D011728:Pyridones / Q000627:therapeutic use; D000069552:Rivaroxaban; D013449:Sulfonamides; D013876:Thiophenes / Q000627:therapeutic use; D054556:Venous Thromboembolism / Q000517:prevention & control*; D015091:beta-Alanine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000925:Anticoagulants; D000991:Antithrombins; D001562:Benzimidazoles; D009025:Morpholines; D010875:Pipecolic Acids; D011720:Pyrazoles; D011728:Pyridones; D013449:Sulfonamides; D013876:Thiophenes; D015091:beta-Alanine; C522181:apixaban; D001120:Arginine; D000069552:Rivaroxaban; D000069604:Dabigatran; C031942:argatroban